FREFIREBRICK PHARMA LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 11 Aug 2026, 18:21 | Cleansing Notice | Securities Administration | — | 06018 | |
| 11 Aug 2026, 18:20 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 10 Aug 2026, 18:41 | Proposed issue of securities - FRE | Securities Administration | — | 06013 | |
| 28 July 2026, 01:26 | Update - Notification regarding unquoted securities - FRE | Other | — | 06021 | |
| 27 July 2026, 19:33 | Investor Update | Presentations | MS | 03026, 19009 | |
| 27 July 2026, 19:32 | June 2026 Quarterly Activity Report | Quarterly Reports | MS | 19004, 19009 | |
| 14 July 2026, 22:00 | Change of Address | Securities Administration | — | 12002, 12003 | |
| 22 June 2026, 21:21 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 3 June 2026, 18:20 | Nasodine Composition Patent Granted in New Zealand | Company Update | — | 11001, 12008 | |
| 2 June 2026, 18:31 | Cleansing Notice | Securities Administration | — | 06018 | |
| 2 June 2026, 18:29 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 1 June 2026, 18:40 | Proposed issue of securities - FRE | Securities Administration | — | 06013 | |
| 1 June 2026, 18:24 | Notification of cessation of securities - FRE | Other | — | 06027 | |
| 30 May 2026, 05:11 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 22 May 2026, 19:23 | Notice of GM & Proxy Form & Access Letter | Meetings & Governance | — | 08004, 08007, 16002 | |
| 22 May 2026, 02:59 | Cleansing Notice | Securities Administration | — | 06018 | |
| 22 May 2026, 02:58 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 21 May 2026, 20:10 | Change of Director's Interest Notice - Peter Molloy | Director Interests | — | 02009 | |
| 21 May 2026, 19:02 | Change of Director's Interest Notice - Stephen Goodall | Director Interests | — | 02009 | |
| 21 May 2026, 02:50 | Close of Offer - Listing Options | Securities Administration | — | 06009 | |
| 15 May 2026, 19:31 | Cleansing Prospectus - Listing of Options | Securities Administration | — | 06009, 06010 | |
| 15 May 2026, 00:57 | Options Top 20 Holders Report | Securities Administration | — | 03002 | |
| 15 May 2026, 00:55 | Options Range Report | Securities Administration | — | 06009 | |
| 15 May 2026, 00:54 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 13 May 2026, 22:17 | Nasodine patent accepted in Canada | Company Update | — | 11001 | |
| 22 Apr 2026, 21:02 | Firebrick investor webinar update | Presentations | — | 14014 | |
| 22 Apr 2026, 02:50 | March 2026 Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 02:54 | Notification regarding unquoted securities - FRE | Other | — | 06021 | |
| 18 Apr 2026, 01:39 | Change in substantial holding - Stephen Goodall | Substantial Holders | — | 02002 | |
| 17 Apr 2026, 23:03 | Change in substantial holding - Peter Molloy | Substantial Holders | — | 02002 | |
| 17 Apr 2026, 18:25 | Cleansing Notice | Securities Administration | — | 06018 | |
| 17 Apr 2026, 18:25 | Notification regarding unquoted securities - FRE | Other | — | 06021 | |
| 17 Apr 2026, 18:24 | Notification regarding unquoted securities - FRE | Other | — | 06021 | |
| 17 Apr 2026, 18:24 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 14 Apr 2026, 18:18 | Notification of cessation of securities - FRE | Other | — | 06027 | |
| 14 Apr 2026, 04:57 | Cleansing Notice | Securities Administration | — | 06018 | |
| 14 Apr 2026, 04:55 | Notification regarding unquoted securities - FRE | Other | — | 06021 | |
| 14 Apr 2026, 04:52 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 14 Apr 2026, 04:50 | Application for quotation of securities - FRE | Other | — | 06020 | |
| 31 Mar 2026, 20:12 | Proposed issue of securities - FRE | Securities Administration | — | 06013 | |
| 31 Mar 2026, 20:12 | Firebrick Secures $1.5 million via Placement | Capital Raising | MS | 06003, 09014 | |
| 27 Mar 2026, 20:17 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 27 Mar 2026, 19:55 | Registration Agreement and Approval of Nasodine in Indonesia | Company Update | MS | 11001 | |
| 19 Mar 2026, 20:58 | Firebrick to present at NWR Virtual Healthcare Conference | Presentations | — | 12008, 14014 | |
| 18 Mar 2026, 19:38 | Nasodine patent accepted in the Philippines | Company Update | — | 11001 | |
| 17 Mar 2026, 19:22 | FRE appoints Head of Business Development and Licensing | Company Administration | — | 12008 | |
| 4 Mar 2026, 19:31 | Firebrick Investor Update Presentation | Presentations | — | 03026 | |
| 2 Mar 2026, 19:18 | Initial Director's Interest Notice - Al Moghaddam | Director Interests | — | 02008 | |
| 24 Feb 2026, 23:52 | Appendix 4D & Half-Year Financial Report to 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 19 Feb 2026, 23:13 | Release of Securities from Voluntary Escrow | Securities Administration | — | 06009 |
1–50 of 95
1 / 2